This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and the general public through innovative biomedical research. As a private research university, Stanford University has a history of conducting academic research on topics spanning biomedicine, physics, environmental science, and other areas, often in partnership with other institutions, under federal grants and contracts.
Generated 4/23/24, 9:42 AM